Page 2

  • Joaquin Duato
    Image attribution tooltip
    Kevin Dietsch via Getty Images
    Image attribution tooltip

    5 Big Pharma CEOs who saw major pay bumps in 2023

    Pharma’s recent wins have led to pay windfalls for several company leaders.

  • Bianca Anghelina, CEO, founder, Aily Labs
    Image attribution tooltip
    Permission granted by Aily Labs
    Image attribution tooltip

    Ex-Novartis exec sets out to create ‘Apple of AI’

    Aily Labs’ tech makes predictive business decisions for life science companies and comes from a need its founder witnessed in Big Pharma.

  • brain pills
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    After Amylyx drug failure, what’s next for ALS?

    The company’s combo treatment Relyvrio was approved in 2022, but after failing a phase 3 trial, may be pulled from the market.

  • U.S. President Joe Biden
    Image attribution tooltip
    Alex Wong/Getty Images via Getty Images
    Image attribution tooltip
    Q&A

    Former U.S. patent head on why federal march-in rights for drugs would be a ‘devastating’ mistake

    A Biden administration proposal to seize patents for drugs deemed too pricey would have a ripple effect that cuts into the heart of innovation, says former U.S. PTO head Andrei Iancu.